Anaïs F. M. Noisier
Anaïs F. M. Noisier is a Senior Researcher in the Research and Early Development Cardiovascular, Renal and Metabolism (CVRM)| BioPharmaceuticals R&D departement at AstraZeneca, Sweden. Anaïs obtained her PhD in 2013 under the guidance of Prof. Margaret A. Brimble at the University of Auckland, New Zealand. She then worked as a Marie Skłodowska-Curie postdoctoral fellow at the Institute for Research in Biomedicine (IRB Barcelona), Spain, in the group of Prof. Fernando Albericio. In 2016, Anaïs joined AstraZeneca as a post-doctoral fellow. Since 2018, she is a Senior Researcher in the New Modalities team. Her expertise includes the synthesis and medicinal chemistry of therapeutic peptides, she is particularly interested in the development of new methodologies for the Late-Stage Functionalization (LSF) of peptides.